NewEdge Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-281	Closed	-$2.84K	–	3655
2022 Q4	$2.84K	Buy	+281	New	+$2.84K	﹤0.01%	2742
2019 Q4	–	Sell	-12,328	Closed	-$168K	–	830
2019 Q3	$168K	Buy	+12,328	New	+$168K	0.01%	766